Medtronic PLC (MDT)

79.12
+0.10(+0.13%)
After Hours
79.33
+0.21(+0.27%)
- Real-time Data
  • Volume:
    4,879,750
  • Day's Range:
    78.75 - 79.72
  • 52 wk Range:
    76.62 - 114.44

MDT Overview

Prev. Close
79.02
Day's Range
78.75-79.72
Revenue
30.57B
Open
79.32
52 wk Range
76.62-114.44
EPS
3.24
Volume
4,879,750
Market Cap
104.94B
Dividend (Yield)
2.72
(3.44%)
Average Volume (3m)
6,581,487
P/E Ratio
24.14
Beta
0.778
1-Year Change
-28.75%
Shares Outstanding
1,329,153,289
Next Earnings Date
Feb 21, 2023
What is your sentiment on Medtronic?
or
Market is currently closed. Voting is open during market hours.

Medtronic PLC News

Medtronic PLC Analysis

Medtronic PLC Company Profile

Medtronic PLC Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company’s Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company’s Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Read More

Analyst Price Target

Average97.97 (+23.83% Upside)
High142.3
Low79
Price79.12
No. of Analysts24
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellStrong Sell
Technical IndicatorsBuySellStrong BuyStrong SellStrong Sell
SummaryStrong BuyNeutralNeutralStrong SellStrong Sell
  • Partnered with Titan Medical inc(TSX:TMD), (NASDAQ:TMDI) will help Medtronic beat Intuitive Surgical in the robotic sector!
    0
    • medtronic will hit $125.00. before it stabilizes. I'm all in!
      0